| Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589 DZ Qian, Y Kato, S Shabbeer, Y Wei, HMW Verheul, B Salumbides, ... Clinical Cancer Research 12 (2), 634-642, 2006 | 322 | 2006 |
| The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor … DZ Qian, X Wang, SK Kachhap, Y Kato, Y Wei, L Zhang, P Atadja, R Pili Cancer research 64 (18), 6626-6634, 2004 | 280 | 2004 |
| Sequence Diversity of the Intergenic Spacer Region of the rRNA Gene of Malassezia globosa Colonizing the Skin of Patients with Atopic Dermatitis and Healthy … T Sugita, M Kodama, M Saito, T Ito, Y Kato, R Tsuboi, A Nishikawa Journal of clinical microbiology 41 (7), 3022-3027, 2003 | 121 | 2003 |
| Synergistic In vivo Antitumor Effect of the Histone Deacetylase Inhibitor MS-275 in Combination with Interleukin 2 in a Murine Model of Renal Cell Carcinoma Y Kato, K Yoshimura, T Shin, H Verheul, H Hammers, TB Sanni, ... Clinical cancer research 13 (15), 4538-4546, 2007 | 104 | 2007 |
| Integrin α2 mediates selective metastasis to the liver K Yoshimura, KF Meckel, LS Laird, CY Chia, JJ Park, KL Olino, ... Cancer research 69 (18), 7320-7328, 2009 | 99 | 2009 |
| Epigenetic modulation of retinoic acid receptor β2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma X Wang, DZ Qian, M Ren, Y Kato, Y Wei, L Zhang, Z Fansler, D Clark, ... Clinical cancer research 11 (9), 3535-3542, 2005 | 93 | 2005 |
| Antitumor activity of the histone deacetylase inhibitor MS‐275 in prostate cancer models DZ Qian, YF Wei, X Wang, Y Kato, L Cheng, R Pili The Prostate 67 (11), 1182-1193, 2007 | 82 | 2007 |
| Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-cis-retinoic acid in human malignant melanoma Y Kato, BC Salumbides, XF Wang, DZ Qian, S Williams, Y Wei, TB Sanni, ... Molecular cancer therapeutics 6 (1), 70-81, 2007 | 76 | 2007 |
| Improvement of dermatitis by iontophoretically delivered antisense oligonucleotides for interleukin-10 in NC/Nga mice. TS Sakamoto T, Miyazaki E, Aramaki Y, Arima H, Takahashi M, Kato Y, Koga M Gene Ther 11, 317-324, 2004 | 62 | 2004 |
| Characteristics of metallic oxide magnet Y Kato, T Takei J Inst Electr Eng Jpn 53, 408-412, 1933 | 57 | 1933 |
| Induction of apoptosis and/or necrosis following exposure to antitumour agents in a melanoma cell line, probably through modulation of Bcl-2 family proteins H Shibuya, Y Kato, M Saito, T Isobe, R Tsuboi, M Koga, H Toyota, ... Melanoma research 13 (5), 457-464, 2003 | 55 | 2003 |
| Neuere Entwicklungen im Kostenmanagement H Ammann, M Bromwich, GW Diekhöner, CC Freidank, B Friedl, ... Haupt, 1994 | 53 | 1994 |
| Response to hydroxychloroquine in Japanese patients with lupus-related skin disease using the cutaneous lupus erythematosus disease area and severity index (CLASI) N Yokogawa, A Tanikawa, M Amagai, Y Kato, Y Momose, S Arai, H Eto, ... Modern rheumatology 23 (2), 318-322, 2013 | 48 | 2013 |
| Over-expression of AIF-1 in liver allografts and peripheral blood correlates with acute rejection after transplantation in rats Y Nagakawa, S Nomoto, Y Kato, RA Montgomery, GM Williams, AS Klein, ... American Journal of Transplantation 4 (12), 1949-1957, 2004 | 47 | 2004 |
| Effects of hypothalamic lesions on body temperature in the chicken. S Kanematsu, M Kii, T Sonoda, Y Kato | 41 | 1967 |
| The Basidiomycetous Yeasts Cryptococcus diffluens and C. liquefaciens Colonize the Skin of Patients with Atopic Dermatitis T Sugita, M Saito, T Ito, Y Kato, R Tsuboi, S Takeuchi, A Nishikawa Microbiology and immunology 47 (12), 945-950, 2003 | 36 | 2003 |
| Magnetic Properties of Fe~ 1~ 6N~ 2 Fine Particles T Hattori, N Kamiya, Y Kato JOURNAL-MAGNETICS SOCIETY OF JAPAN 25 (4/2), 927-930, 2001 | 30 | 2001 |
| Detonation temperature of nitromethane and some solid high explosives Y Kato, N Mori, H Sakai, K Tanaka, T Sakurai, T Hikita Proceedings of 8th Symposium on Detonation. Albuquerque, New Mexico, 558-565, 1985 | 30 | 1985 |
| Combination of HDAC inhibitor MS-275 and IL-2 increased anti-tumor effect in a melanoma model via activated cytotoxic T cells Y Kato, I Yoshino, C Egusa, T Maeda, R Pili, R Tsuboi Journal of dermatological science 75 (2), 140-147, 2014 | 27 | 2014 |
| Phase I and pharmacokinetic study of the oral histone deacetylase inhibitor vorinostat in Japanese patients with relapsed or refractory cutaneous T‐cell lymphoma H Wada, R Tsuboi, Y Kato, M Sugaya, K Tobinai, T Hamada, ... The Journal of Dermatology 39 (10), 823-828, 2012 | 26 | 2012 |
